369 F.Supp.2d 876 (E.D.Tex. 2005), 6 04CV292, Cartwright v. Pfizer, Inc.
Linked as:
Extract
369 F.Supp.2d 876 (E.D.Tex. 2005), 6 04CV292, Cartwright v. Pfizer, Inc.
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products described in section 201.56(b)(1)
- Code of Federal Regulations - Supplements and other changes to an approved NDA
- US Code - 21 U.S.C. § 360k State and Local Requirements Respecting Devices
- US Code - 21 U.S.C. § 393 Food and Drug Administration
- Code of Federal Regulations - Definitions
